Overview
C10 Labs is a Cambridge-based venture studio fund that builds and supports AI-first startups across healthcare, legal, and medical devices. It offers a unified platform combining AI expertise with hands-on mentorship and operational support, and its products include AI SaaS for FDA denials in the medical device industry, clinical claims revenue-cycle management, and legal research platforms, plus AI-driven tools for early diagnosis and treatment of chronic diseases. It also helps startups deploy scalable AI infrastructure across cloud and on-premises environments. Its goal is to create meaningful AI ventures that boost efficiency, reduce costs, and improve decision-making in its target sectors.
Work here?Claim your company
Simplify's take
What believers are saying
- Round Funded lists 40-plus portfolio companies and a latest deal in April 2026.
- Ekai raised $1.7 million in September 2026 with C10 Labs participation.
- The Applied AI Accelerator targets healthcare, life sciences, and financial services founders.
What critics are saying
- Pega Ventures can train founders without C10, shrinking C10's accelerator bargaining power.
- A single April 2026 deal record signals thin public momentum and uneven deployment.
- If AI Biohub misses traction, C10's second fund ties up capital in specialized healthcare.
What makes C10 Labs unique
- C10 Labs embeds operators and engineers directly into teams through its accelerator model.
- Its May 2026 Pega partnership adds enterprise workflow access and up to $300,000.
- C10's second-fund hiring for AI Biohub with LabCentral extends healthcare venture creation.
Help us improve and share your feedback! Did you find this helpful?